Reproductive Genetics Institute PGT-A Testing Marketing Class Action
Reproductive Genetics Institute · Preimplantation genetic testing for aneuploidy (PGT-A) and embryo storage services
About this case
A class action filed in 2024 alleges that Reproductive Genetics Institute misrepresented the accuracy of its preimplantation genetic testing for aneuploidy (PGT-A), causing patients to pay for testing that allegedly produced false positives and led them to discard viable embryos. The underlying class action's current procedural stage is not specified; a separate federal coverage ruling held that Landmark American Insurance did not owe RGI a defense or indemnification.
Case overview
- Defendant company
- Reproductive Genetics Institute
- Product or service
- Preimplantation genetic testing for aneuploidy (PGT-A) and embryo storage services
- Court case number
- 24-09535 (N.D. Ill.)
- Lawsuit type
- Consumer
- Reported harm
- False Advertising
Participation information
Availability is based on each listed participation option and its deadline.
No active participation options are currently listed.
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Reproductive Genetics Institute PGT-A Testing Marketing Class Action
Business Insurance ·